| HOME >> BIOLOGY >> TECHNOLOGY |
Nancy Linck Extends Firm's Life Sciences Capabilities
WASHINGTON, Jan. 10 /PRNewswire/ -- Rothwell, Figg, Ernst & Manbeck, P.C. announced today that Dr. Nancy J. Linck will join the firm in an Of Counsel position, effective Feb. 4, 2008. Dr. Linck has served as the former Solicitor and later an Administrative Patent Judge at the U.S. Patent & Trademark Office (USPTO), former Deputy General Counsel, IP & Trade, for the Biotechnology Industry Organization (BIO), and Senior Vice President, Intellectual Property and Regulatory Affairs and Chief Compliance Counsel, for Guilford Pharmaceuticals.
Dr. Linck commented that, "Rothwell, Figg, Ernst & Manbeck will provide an exceptional environment for me to return to private practice, and I am delighted to join what I have long regarded as one of the nation's leading intellectual property law firms."
"Rothwell Figg has, over many years, developed a strong biotechnology and pharmaceutical practice, and Nancy's extensive intellectual property expertise in these fields will help us expand our reach and continue to offer excellent service to our clients in these industries," Tony Figg of Rothwell, Figg, Ernst & Manbeck, P.C. said. "Nancy is one of the country's top IP lawyers, and her experience in private and corporate practice, as a frequent advocate for the USPTO in the Federal Circuit, and as a member of the Board of Patent Appeals and Interferences puts her in an extraordinary position to represent and counsel clients in a wide range of capacities."
The addition of Dr. Linck to the Rothwell Figg team is particularly
timely in light of upcoming changes in the pharmaceutical and biotechnology
markets. An estimated $29 billion worth of pharmaceutical patents are set
to expire in the next two years, which will likely result in an increase in
patent disputes as companies attempt to protect or extend their patents.
Rothwell Figg will be well-positioned to advise companies on these matters.
'/>"/>
| SOURCE Rothwell, Figg, Ernst & Manbeck, P.C. Copyright©2008 PR Newswire. All rights reserved |